Spots Global Cancer Trial Database for becatecarin
Every month we try and update this database with for becatecarin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors | NCT00086983 | Unspecified Adu... | becatecarin oxaliplatin pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia | NCT00087204 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... Secondary Myelo... | becatecarin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00005085 | Colorectal Canc... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer | NCT00006262 | Ovarian Cancer | becatecarin | 21 Years - | Northwestern University | |
| Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer | NCT00005027 | Kidney Cancer | becatecarin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia | NCT00087204 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... Secondary Myelo... | becatecarin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | NCT00084487 | Extensive Stage... Limited Stage S... Recurrent Small... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer | NCT00006262 | Ovarian Cancer | becatecarin | 21 Years - | Northwestern University | |
| XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | NCT00090025 | Biliary Tract C... | becatecarin 5-Fluorouracil ... | 18 Years - | Helsinn Healthcare SA | |
| Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma | NCT00003737 | Neuroblastoma | becatecarin | - 18 Years | Memorial Sloan Kettering Cancer Center | |
| Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer | NCT00006017 | Lung Cancer | becatecarin | - | Case Comprehensive Cancer Center | |
| Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer | NCT00005997 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | becatecarin | 18 Years - | Case Comprehensive Cancer Center | |
| Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia | NCT00087204 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... Secondary Myelo... | becatecarin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia | NCT00087204 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... Secondary Myelo... | becatecarin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | NCT00084487 | Extensive Stage... Limited Stage S... Recurrent Small... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors | NCT00086983 | Unspecified Adu... | becatecarin oxaliplatin pharmacological... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
